Loading company…
Treadwell Therapeutics develops first-in-class cancer treatments, including small molecules, biologics and T-cell receptor cell therapies.
Founded by Mark Bray and Shane Burgess, Treadwell Therapeutics is a biotechnology company based in New York, US, focused on oncology therapeutics. In November 2021, it raised USD 91.00 mn in Series B funding, co-led by 3W Fund Management and Sino Biopharmaceutical, with participation from multiple investors. The company plans to use the funds to advance its product candidates and build its organization, with a focus on North America and Europe.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in